These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3566092)

  • 21. Effect of clofibric acid and tiadenol on peroxisomal beta-oxidation and fatty acid binding protein in intestinal mucosa of rats.
    Kawashima Y; Takegishi M; Watanuki H; Katoh H; Tachibana Y; Kozuka H
    Toxicol Appl Pharmacol; 1985 May; 78(3):363-9. PubMed ID: 4049386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tiadenol and di-(2-ethylhexyl)phthalate on the metabolism of phosphatidylcholine and phosphatidylethanolamine in the liver of rats: comparison with clofibric acid.
    Mizuguchi H; Kudo N; Ohya T; Kawashima Y
    Biochem Pharmacol; 1999 Apr; 57(8):869-76. PubMed ID: 10086319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of catalase and oxidative stress in hepatic peroxisome proliferator-induced morphological transformation of Syrian hamster embryo cells.
    Mikalsen SO; Kaalhus O; Reith A; Sanner T
    Int J Cancer; 1990 Nov; 46(5):950-7. PubMed ID: 2172174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of cholesterogenesis regulation in the liver and prostate of the BIO 87.20 hamster.
    Schaffner CP; Brill DR; Singhal AK; Bonner DP; Goldstein NI; Wang GM
    Lipids; 1981 Nov; 16(11):835-40. PubMed ID: 7311743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-metabolizing enzymes, CoASH and long-chain acyl-CoA in rat liver after treatment with tiadenol, nicotinic acid and niadenate.
    Bakke OM; Berge RK
    Biochem Pharmacol; 1982 Dec; 31(23):3930-3. PubMed ID: 7159471
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of clofibric acid and tiadenol on cytosolic long-chain acyl-CoA hydrolase and peroxisomal beta-oxidation in liver and extrahepatic tissues of rats.
    Katoh H; Kawashima Y; Watanuki H; Kozuka H; Isono H
    Biochim Biophys Acta; 1987 Jul; 920(2):171-9. PubMed ID: 2886154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of S-8527 (1,1-bis(4'-(1'-carboxy-1'-methylpropoxy)phenyl) cyclohexane), a new hypolipidemic compound, on cholesterol and lipoprotein metabolism in rats.
    Suzuki K
    Biochem Pharmacol; 1976 Feb; 25(3):325-8. PubMed ID: 1267828
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.
    Ringseis R; Pösel S; Hirche F; Eder K
    Pharmacol Res; 2007 Aug; 56(2):175-83. PubMed ID: 17644405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypolipidemic effects of dietary 7-oxo-24,25-dihydrolanosterol.
    Sonoda Y; Sato Y
    J Pharmacobiodyn; 1985 Jul; 8(7):518-24. PubMed ID: 4067814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypolipidemic effect of ethyl all-cis-5,8,11,14,17-eicosapentaenoate (EPA-E) in rats.
    Mizuguchi K; Yano T; Kojima M; Tanaka Y; Ishibashi M; Masada A; Sato M; Mizota M; Fukutake K; Saito Y
    Jpn J Pharmacol; 1992 Jul; 59(3):307-12. PubMed ID: 1434127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hypolipidemic drugs on hepatic CoA.
    Halvorsen O
    Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
    Berman JS; Hiley CR; Wilson AC
    Br J Pharmacol; 1983 Mar; 78(3):533-41. PubMed ID: 6839062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Wy-14,643 on cholesterol metabolism in normal and hypercholesterolemic rats.
    Tomarelli RM; Bauman LM; Savini S
    Atherosclerosis; 1978 Aug; 30(4):301-11. PubMed ID: 708488
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-hyperlipidemic effect of iodine eggs: studies on the mechanism of its action].
    Kaji K; Miyashita M; Seyama Y; Yamashita S
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):451-7. PubMed ID: 6469134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of clofibrate and halofenate (MK-185) in isolated rat hepatocytes.
    Homcy CJ; Margolis S
    Atherosclerosis; 1974; 19(3):381-91. PubMed ID: 4828566
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
    Morishita S; Saito T; Hirai Y; Shoji M; Mishima Y; Kawakami M
    J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet.
    Chan PT; Fong WP; Cheung YL; Huang Y; Ho WK; Chen ZY
    J Nutr; 1999 Jun; 129(6):1094-101. PubMed ID: 10356071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
    Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F
    J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of soybean phospholipid, chlorella phospholipid, and clofibrate on collagen and elastin synthesis in the aorta and on the serum and liver lipid contents in rats.
    Hashimoto S; Setoyama T; Yokokura T; Mutai M
    Exp Mol Pathol; 1982 Feb; 36(1):99-106. PubMed ID: 7198996
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
    Orton TC; Parker GL
    Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.